title: Role of 2B4-mediated signals in the pathogenesis of a murine hepatitis model independent of Fas and Valpha14 NKT cells.
abstract: Concanavalin A (Con A)-induced hepatitis is a T-cell-mediated murine experimental model of autoimmune hepatitis. Mice lacking Valpha14 NKT cells were found to be less sensitive to this hepatitis and the MRL/Mp-Fas(lpr/lpr) (MRL/lpr; i.e. Fas deficient) mice were also less sensitive. We report herein that MRL/Mp-Fas(lpr/lpr)-Sap(rpl/-) (MRL/lpr/rpl) mice lack Valpha14 NKT cells and are deficient in the Fas antigen but sensitive to Con A-induced hepatitis. The signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is an adaptor molecule containing a Src homology 2 (SH2) domain. We previously reported new mutant mice found among MRL/lpr mice and revealed that SAP deficiency led to the regression of autoimmune phenotypes in mutant MRL/lpr/rpl mice. It was also revealed that CD4(+) and CD8(+) T cells were effector cells and that blockade of 2B4, one of the SLAM family receptors, inhibited the induction of hepatitis in MRL/lpr/rpl mice. These data suggest that signals mediated by molecules other than SAP from 2B4 in T cells played important roles in the induction of hepatitis in MRL/lpr/rpl mice.
authors.affiliation: Department of Pathology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan. hfurukawa@mail.tains.tohoku.ac.jp
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Furukawa
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kitazawa
authors.forename: Izumi
authors.initials: I
authors.lastname: Kaneko
authors.forename: Mitsunobu
authors.initials: M
authors.lastname: Matsubara
authors.forename: Masato
authors.initials: M
authors.lastname: Nose
authors.forename: Masao
authors.initials: M
authors.lastname: Ono
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003208:Concanavalin A / Q000008:administration & dosage / Q000494:pharmacology; D004195:Disease Models, Animal; D019693:Hepatitis, Autoimmune / Q000276:immunology*; D007155:Immunologic Factors / Q000494:pharmacology; D015847:Interleukin-4 / Q000276:immunology / Q000378:metabolism; D051379:Mice; D019463:Mice, Inbred MRL lpr; D008817:Mice, Mutant Strains; D008934:Mitogens / Q000008:administration & dosage / Q000494:pharmacology; D055611:Natural Killer T-Cells / Q000276:immunology*; D011971:Receptors, Immunologic / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D000071176:Signaling Lymphocytic Activation Molecule Family; D019014:fas Receptor / Q000235:genetics / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C490007:Cd244a protein, mouse; D007155:Immunologic Factors; D008934:Mitogens; D011971:Receptors, Immunologic; D000071176:Signaling Lymphocytic Activation Molecule Family; D019014:fas Receptor; D003208:Concanavalin A; D015847:Interleukin-4
references.citation: J Clin Invest. 1992 Jul;90(1):196-203
references.pmid: 1634608
references.citation: Nature. 1992 Mar 26;356(6367):314-7
references.pmid: 1372394
references.citation: J Immunol. 1997 Aug 1;159(3):1418-28
references.pmid: 9233639
references.citation: J Immunol. 1997 Aug 1;159(3):1537-42
references.pmid: 9233653
references.citation: Nature. 1998 Oct 1;395(6701):462-9
references.pmid: 9774102
references.citation: Eur J Immunol. 1998 Dec;28(12):4105-13
references.pmid: 9862346
references.citation: Nat Med. 2005 Mar;11(3):340-5
references.pmid: 15711562
references.citation: Curr Opin Immunol. 2005 Apr;17(2):122-30
references.pmid: 15766670
references.citation: Immunol Lett. 2005 Aug 15;100(1):42-55
references.pmid: 16083968
references.citation: J Immunol. 2006 Jan 1;176(1):395-400
references.pmid: 16365433
references.citation: J Immunol. 2006 Feb 1;176(3):1618-27
references.pmid: 16424191
references.citation: Nat Rev Immunol. 2006 Jan;6(1):56-66
references.pmid: 16493427
references.citation: J Clin Invest. 2006 Apr;116(4):1045-51
references.pmid: 16557300
references.citation: Nat Immunol. 2006 Sep;7(9):987-94
references.pmid: 16878136
references.citation: Immunol Rev. 2006 Dec;214:22-34
references.pmid: 17100873
references.citation: J Exp Med. 2000 Jan 3;191(1):105-14
references.pmid: 10620609
references.citation: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5498-503
references.pmid: 10792025
references.citation: J Leukoc Biol. 2002 Aug;72(2):262-70
references.pmid: 12149416
references.citation: J Immunol. 2003 Aug 15;171(4):2142-53
references.pmid: 12902521
references.citation: Nat Rev Immunol. 2003 Oct;3(10):813-21
references.pmid: 14523387
references.citation: J Immunol. 2003 Oct 15;171(8):4439-46
references.pmid: 14530371
references.citation: Immunity. 2004 Oct;21(4):539-50
references.pmid: 15485631
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1756-60
references.pmid: 7680478